Cargando…

Design and Characterization of pMyc/pMax Peptide-Coupled Gold Nanosystems for Targeting Myc in Prostate Cancer Cell Lines

Myc and Max are essential proteins in the development of prostate cancer. They act by dimerizing and binding to E-box sequences. Disrupting the Myc:Max heterodimer interaction or its binding to E-box sequences to interrupt gene transcription represent promising strategies for treating cancer. We des...

Descripción completa

Detalles Bibliográficos
Autores principales:	Longoria-García, Samuel, Sánchez-Domínguez, Celia N., Sánchez-Domínguez, Margarita, Delgado-Balderas, Jesús R., Islas-Cisneros, José F., Vidal-Gutiérrez, Oscar, Gallardo-Blanco, Hugo L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609645/ https://www.ncbi.nlm.nih.gov/pubmed/37887952 http://dx.doi.org/10.3390/nano13202802

Ejemplares similares

Recent applications of cell-penetrating peptide guidance of nanosystems in breast and prostate cancer
por: Longoria-García, Samuel, et al.
Publicado: (2022)

Max deletion destabilizes MYC protein and abrogates Eµ-Myc lymphomagenesis
por: Mathsyaraja, Haritha, et al.
Publicado: (2019)

A selective high affinity MYC-binding compound inhibits MYC:MAX interaction and MYC-dependent tumor cell proliferation
por: Castell, Alina, et al.
Publicado: (2018)

MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner
por: Castell, Alina, et al.
Publicado: (2022)

Mnt–Max to Myc–Max complex switching regulates cell cycle entry
por: Walker, William, et al.
Publicado: (2005)

MYC-Associated Factor MAX is a Regulator of the Circadian Clock
por: Blaževitš, Olga, et al.
Publicado: (2020)

A MYC inhibitor selectively alters the MYC and MAX cistromes and modulates the epigenomic landscape to regulate target gene expression
por: Holmes, Austin G., et al.
Publicado: (2022)

Oesophageal adenocarcinoma is associated with a deregulation in the MYC/MAX/MAD network
por: Boult, J K R, et al.
Publicado: (2008)

In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potential
por: Raffeiner, Philipp, et al.
Publicado: (2014)

Functional Myc-Max heterodimer is required for activation-induced apoptosis in T cell hybridomas
Publicado: (1994)

Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids
por: Wang, Huabo, et al.
Publicado: (2015)

RUNX3 inactivates oncogenic MYC through disruption of MYC/MAX complex and subsequent recruitment of GSK3β-FBXW7 cascade
por: Oei, Vincent, et al.
Publicado: (2023)

Myc and Max Genome-Wide Binding Sites Analysis Links the Myc Regulatory Network with the Polycomb and the Core Pluripotency Networks in Mouse Embryonic Stem Cells
por: Krepelova, Anna, et al.
Publicado: (2014)

C-myc and N-myc in the developing brain
por: Wey, Alice, et al.
Publicado: (2010)

MYC Immunohistochemistry Predicts MYC Rearrangements by FISH
por: Nwanze, Julum, et al.
Publicado: (2017)

The Molecular ‘Myc-anisms’ Behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics
por: McAnulty, Jessica, et al.
Publicado: (2020)

Role of Pirh2 in Mediating the Regulation of p53 and c-Myc
por: Hakem, Anne, et al.
Publicado: (2011)

Myc/Max dependent intronic long antisense noncoding RNA, EVA1A-AS, suppresses the expression of Myc/Max dependent anti-proliferating gene EVA1A in a U2 dependent manner
por: Niehus, Svenja E., et al.
Publicado: (2019)

Differential expression of myc, max and RB1 genes in human gliomas and glioma cell lines.
por: Hirvonen, H. E., et al.
Publicado: (1994)

Viral mutations enhance the Max binding properties of the vMyc b-HLH-LZ domain
por: Crouch, D. H., et al.
Publicado: (2005)

The Max b-HLH-LZ Can Transduce into Cells and Inhibit c-Myc Transcriptional Activities
por: Montagne, Martin, et al.
Publicado: (2012)

Sequence-specific DNA binding by MYC/MAX to low-affinity non-E-box motifs
por: Allevato, Michael, et al.
Publicado: (2017)

MYC–MAX heterodimerization is essential for the induction of major zygotic genome activation and subsequent preimplantation development
por: Yamamoto, Takuto, et al.
Publicado: (2023)

Novel dual-targeting c-Myc inhibitor D347-2761 represses myeloma growth via blocking c-Myc/Max heterodimerization and disturbing its stability
por: Yao, Ruosi, et al.
Publicado: (2022)

Green Synthesis of Mesquite-Gum-Stabilized Gold Nanoparticles for Biomedical Applications: Physicochemical Properties and Biocompatibility Assessment
por: Pinilla-Torres, Ana M., et al.
Publicado: (2023)

Characterization of ARF-BP1/HUWE1 Interactions with CTCF, MYC, ARF and p53 in MYC-Driven B Cell Neoplasms
por: Qi, Chen-Feng, et al.
Publicado: (2012)

Myc interacts with Max and Miz1 to repress C/EBPδ promoter activity and gene expression
por: Si, Junling, et al.
Publicado: (2010)

Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5
por: Wang, Huabo, et al.
Publicado: (2013)

MYCN and MAX alterations in Wilms tumor and identification of novel N-MYC interaction partners as biomarker candidates
por: Jiménez Martín, Ovidio, et al.
Publicado: (2021)

Validation of Myc-Associated Protein X (MAX) regulation in growth hormone secreting and nonfunctional pituitary adenoma
por: Tucker, Douglass W., et al.
Publicado: (2023)

Evaluation of p62c-myc in benign and malignant gastric epithelia.
por: Allum, W. H., et al.
Publicado: (1987)

p300- and Myc-mediated regulation of glioblastoma multiforme cell differentiation
por: Panicker, Sreejith P., et al.
Publicado: (2010)

Wild-type p53 binds to MYC promoter G-quadruplex
por: Petr, Marek, et al.
Publicado: (2016)

Cross-talk between Myc and p53 in B-cell lymphomas
por: Yu, Li, et al.
Publicado: (2019)

P851: TARGETING GENE DEPENDENCIES IN MYC OVEREXPRESSING MULTIPLE MYELOMA
por: Hasan Bou Issa, L., et al.
Publicado: (2022)

Alterations and Co-Occurrence of C-MYC, N-MYC, and L-MYC Expression are Related to Clinical Outcomes in Various Cancers
por: Lee, Moonjung, et al.
Publicado: (2023)

MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2015)

Myc-regulated miRNAs modulate p53 expression and impact animal survival under nutrient deprivation
por: Gervé, María P., et al.
Publicado: (2023)

Myc stimulates cell cycle progression through the activation of Cdk1 and phosphorylation of p27
por: García-Gutiérrez, Lucía, et al.
Publicado: (2019)

MYC-type transcription factors, MYC67 and MYC70, interact with ICE1 and negatively regulate cold tolerance in Arabidopsis
por: Ohta, Masaru, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5285375p6kmvd5aabc9d7k6bkl